NCT00459875View on ClinicalTrials.gov

Sunitinib in Treating Patients With Locally Recurrent or Metastatic Kidney Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

March 31, 2007

Primary Completion Date

November 30, 2010

Study Completion Date

November 30, 2010

Conditions
Kidney Cancer
Interventions
DRUG

sunitinib malate

Trial Locations (1)

10065

Memorial Sloan-Kettering Cancer Center, New York

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Memorial Sloan Kettering Cancer Center

OTHER

NCT00459875 - Sunitinib in Treating Patients With Locally Recurrent or Metastatic Kidney Cancer | Biotech Hunter | Biotech Hunter